Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-24 @ 3:04 PM
NCT ID:
NCT05413759
Eligibility Criteria:
Inclusion Criteria:
* Patient with diagnosed rheumatoid arthritis (RA),
* Patient, male or female, aged 18 or over,
* Patient hospitalized or coming for a consultation in a rheumatology department, and returned home at hospital discharge
* Patient having DMARDs for RA (continuation or initiation) comprising at least methotrexate and/or a tsDMARD (targeted synthetic DMARD, JAK inhibitor) and/or subcutaneous bDMARD (biologic DMARD),
* Autonomous patient in the management of his drug treatment,
* Patient understanding and speaking French,
* Patient affiliated to the French general national health insurance or similar,
* Patient having given his free, informed and signed consent.
Exclusion Criteria:
* Patient whose usual pharmacy already has or has had a patient included in the INTERVENTION group in the study,
* Patient whose regular pharmacy is currently treating another patient.
* Patient with obvious significant cognitive or psychiatric disorders incompatible with the study (according to the judgment of the investigator),
* Patient whose management of his drug treatment at home is carried out exclusively by a carer,
* Patient participating in another research that may interfere (investigator's judgement) with the results of the present study,
* Adult patient protected under the terms of the law (Public Health Code),
* Patient not fit to carry out the follow-up, according to the judgment of the investigator,
* Pregnant or breastfeeding women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05413759
Study Brief:
Protocol Section:
NCT05413759